Coeliac disease

Beyond Celiac Identifies Health Disparities in Celiac Disease Awareness, Diagnosis and Treatment for Black Americans

Retrieved on: 
Tuesday, August 23, 2022

Other research indicates celiac disease diagnosis and treatment disparities for Black Americans.

Key Points: 
  • Other research indicates celiac disease diagnosis and treatment disparities for Black Americans.
  • indicating lack of awareness and health information about celiac disease and/or gluten-sensitivity include:
    Only 8% of Black Americans know that celiac disease often runs in families, compared to 21% of Hispanic Americans and 24% of White Americans.
  • Only 33% of Black Americans are aware that someone with celiac disease who strictly follows a gluten-free diet still has to worry about experiencing celiac disease symptoms or health conditions caused by it, whereas 41% of Hispanic Americans and 56% of White Americans know it.
  • In the Beyond Celiac Voices of Celiac Disease project , non-whites with celiac disease have shared stories of being dismissed by physicians who told them they could not have celiac disease because of their race and, thus delaying diagnosis due to race.

Gastroenterologists' Urgency in Treating Celiac Disease Increases as the Number of Viable Pipeline Candidates Dwindles, According to Spherix Global Insights

Retrieved on: 
Monday, August 8, 2022

EXTON, Pa., Aug. 8, 2022 /PRNewswire/ -- Spherix recently surveyed 100 US gastroenterologists and conducted eight qualitative interviews to assess the current and future management of celiac disease (CeD). The combination of both qualitative and quantitative research included in the Market Dynamix™: Celiac Disease (US) service evaluates the diagnostic and treatment trends emerging with the condition, as well as physician reactions to potential therapies in development.

Key Points: 
  • The 2022 report reveals a greater sense of urgency from gastroenterologists compared to the general sentiment found in last year's report.
  • Correspondingly, more than two-thirds of gastroenterologists indicate a high unmet need for new treatments options compared to 44% the prior year.
  • Spherix's report also identifies the many challenges in treating this patient population, beginning with diagnosis of the condition.
  • Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Gluten-Free Food Market In the UK to Record 6.93% Y-O-Y Growth Rate in 2022, Bakery & Confectionery Products Segment to be Significant for Revenue Generation - Technavio

Retrieved on: 
Friday, August 5, 2022

Gluten-Free Food Market in the UK: Major Driver

Key Points: 
  • Gluten-Free Food Market in the UK: Major Driver
    The key factors driving the gluten-free food market growth in the UK is the increasing awareness of the health benefits of gluten-free food.
  • For instance, the consumption of gluten-free food has increased by 12% from 2013 to 2020 in the UK.
  • Gluten-Free Food Market in the UK: Major Challenges
    The key challenges to the gluten-free food market growth in the UK are the cross-contamination of gluten-free food products when it comes to contact with a food product that is not gluten-free.
  • The competitive scenario provided in the Gluten-Free Food Market In UK report analyzes, evaluates, and positions companies based on various performance indicators.

Global Celiac Disease Epidemiology Forecast to 2032 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 28, 2022

The Celiac Disease (CD) epidemiology report gives a thorough understanding of the Celiac Disease (CD) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis.

Key Points: 
  • The Celiac Disease (CD) epidemiology report gives a thorough understanding of the Celiac Disease (CD) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis.
  • The Celiac Disease (CD) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032.
  • The Celiac Disease (CD) epidemiology covered in the report provides historical as well as forecasted Celiac Disease (CD) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
  • Quantify patient populations in the global Celiac Disease (CD) market to improve product design, pricing, and launch plans
    The Celiac Disease (CD) Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies.

Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis

Retrieved on: 
Wednesday, July 27, 2022

NEW YORK, July 27, 2022 /PRNewswire/ -- Mymee, a leading provider of specialized care and support for people with significant symptoms associated with autoimmune disease and long COVID, has acquired Berlin-based Breakthrough Health, the creator of the #1 mobile app Emilyn for people with multiple sclerosis (MS). With the acquisition, Mymee gains deeper expertise in the unique needs of MS patients and brings on Breakthrough Health's experienced leadership to help scale Mymee's personalized health platform and research.

Key Points: 
  • With the acquisition, Mymee gains deeper expertise inthe unique needs of MS patients and brings on Breakthrough Health's experienced leadership to help scale Mymee's personalized health platform and research.
  • Mymee is dedicated to changing the future of precision research and care for complex autoimmune diseases.
  • In 2021, Breakthrough Health won the MS Challenge from EIT Health for most innovative MS startup and partner for MS patient support.
  • In 2022, Mymee joined NYCHBL's Digital Health 100 as a women's health company to watch and one of the most innovative health startups in New York.

Celiac Disease Epidemiology and Market Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 26, 2022

The "Celiac Disease - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Celiac Disease - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.
  • This "Celiac Disease - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Celiac Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Celiac Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
    The Celiac Disease Epidemiology Report and Model provide an overview of the global trends of Celiac Disease in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
    The report provides insight into the historical and forecasted patient pool of Celiac Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
    Quantify patient populations in the global Celiac Disease market to improve product design, pricing, and launch plans
    The Celiac Disease Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies.
  • Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Marco's Pizza® Introduces Tasty NEW Gluten-Friendly Cauliflower Crust, Available Nationwide

Retrieved on: 
Wednesday, July 13, 2022

TOLEDO, Ohio, July 13, 2022 /PRNewswire/ -- Pizza (and veggie) lovers rejoice! Marco's Pizza is spreading some extra pizza love so everyone can indulge in their favorite food, with the launch of Cauliflower Crust. Marco's adds this new crust type to the menu so fans can enjoy this tasty option all year-round, making it the first national QSR pizza brand to offer a Cauliflower Crust as part of its standard menu offering.

Key Points: 
  • Marco's Pizza is spreading some extra pizza love so everyone can indulge in their favorite food, with the launch of Cauliflower Crust.
  • "We focus on delighting the pizza lover and furthering the overall love of pizza," said Chris Tussing, chief marketing officer at Marco's Pizza.
  • Finding a lighter option and a tasty alternative to traditional pizza can be a struggle, especially for folks with gluten sensitivities.
  • For an additional $2, customers can now enjoy Marco's Cauliflower Crust on any small pizza (average small pizza is $9.99).

Global Celiac Disease Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecasts, and Market Shares 2020-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022

The "Global Celiac Disease Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Celiac Disease Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • This research provides comprehensive insights into Celiac Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Celiac Disease treatment options, Celiac Disease late-stage clinical trials pipeline, Celiac Disease prevalence by countries, Celiac Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Celiac Disease pipeline: Find out drugs in clinical trials for the treatment of Celiac Disease by development phase 3, phase 2, by pharmacological class and company
    Celiac Disease drugs: Identify key drugs marketed and prescribed for Celiac Disease in the US, including trade name, molecule name, and company
    Celiac Disease market valuations: Find out the market size for Celiac Disease drugs in 2020 by countries.

110 Grill® Wins New Hampshire Magazine's Best of NH Award for Best Gluten Free Multilocation Restaurant

Retrieved on: 
Wednesday, June 22, 2022

WESTFORD, Mass., June 22, 2022 /PRNewswire/ -- 110 Grill®, the fastest growing allergy-friendly restaurant brand in the Northeast, has won for the fourth year in a row the New Hampshire Magazine's reader's choice award for Best Gluten-free Options Multilocation Restaurant. More than 14,300 people voted and the results will be published in the July issue of New Hampshire Magazine. 110 Grill's award winning commitment to allergy safety accommodates all allergen needs and the brand is a proud supporter of the Celiac Disease Program at Boston Children's Hospital.

Key Points: 
  • WESTFORD, Mass., June 22, 2022 /PRNewswire/ --110 Grill, the fastest growing allergy-friendly restaurant brand in the Northeast, has won for the fourth year in a row the New Hampshire Magazine's reader's choice award for Best Gluten-free Options Multilocation Restaurant .
  • More than 14,300 people voted and the results will be published in the July issue of New Hampshire Magazine.
  • 110 Grill's award winning commitment to allergy safety accommodates all allergen needs and the brand is a proud supporter of the Celiac Disease Program at Boston Children's Hospital.
  • Our New Hampshire guests trust us and it's an honor that they've selected us again as the best."

Everlywell Releases Tests for Food Allergy and Celiac Disease, Creating a Destination for Affordable Testing for Food Related Conditions Paired with Virtual Follow-Up Care

Retrieved on: 
Wednesday, June 22, 2022

AUSTIN, Texas, June 22, 2022 /PRNewswire/ -- Everlywell, a leading digital healthcare company that provides convenient, affordable, and personalized support for health and wellness, today announced the expansion of its nutritional health category to include even more digestive health solutions, including the release of at-home collection tests for Celiac Disease and Food Allergies paired with virtual and follow-up care. These new tests, developed and validated by leading third-party labs, expand upon Everlywell's Nutritional Health category of products, which today include validated lab tests for Food Sensitivity, Metabolism, common vitamin deficiencies, and the company's newly launched line of vitamins and supplements.

Key Points: 
  • Although the majority of Americans struggle with food-related symptoms, clinical testing for common food-related conditions can be costly and difficult to access, with some tests costing hundreds of dollars.
  • The Food Allergy Test ($149) allows consumers to learn their IgE reactivity to nine common food allergens that are responsible for the majority of adverse reactions related to food allergies.
  • Those who indicate their symptoms are severe on a pre-purchase screener will be discouraged from purchasing a Food Allergy Test and advised to seek in-person care.
  • Today, Everlywell is a destination for products and digital tools that support health and wellness within the home, including telehealth, supplements, and insightful tests from certified labs.